Versant Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104K Buy
830
+459
+124% +$57.6K 0.02% 657
2025
Q1
$50.8K Sell
371
-30
-7% -$4.11K 0.01% 856
2024
Q4
$61.3K Buy
401
+279
+229% +$42.7K 0.01% 501
2024
Q3
$23.6K Sell
122
-32
-21% -$6.2K 0.01% 750
2024
Q2
$35.7K Buy
154
+85
+123% +$19.7K 0.01% 505
2024
Q1
$14.9K Sell
69
-3
-4% -$647 ﹤0.01% 605
2023
Q4
$18.6K Buy
72
+3
+4% +$776 0.01% 523
2023
Q3
$17.7K Sell
69
-13
-16% -$3.34K 0.01% 520
2023
Q2
$23.4K Buy
82
+13
+19% +$3.71K 0.01% 458
2023
Q1
$19.2K Hold
69
0.01% 503
2022
Q4
$19.1K Hold
69
0.01% 461
2022
Q3
$18K Sell
69
-3
-4% -$783 0.01% 442
2022
Q2
$15K Buy
72
+4
+6% +$833 0.01% 513
2022
Q1
$14K Sell
68
-7
-9% -$1.44K ﹤0.01% 575
2021
Q4
$18K Hold
75
0.01% 528
2021
Q3
$21K Hold
75
0.01% 448
2021
Q2
$26K Hold
75
0.01% 393
2021
Q1
$21K Hold
75
0.01% 531
2020
Q4
$18K Hold
75
0.01% 530
2020
Q3
$21K Sell
75
-3
-4% -$840 0.01% 409
2020
Q2
$20K Sell
78
-8
-9% -$2.05K 0.01% 412
2020
Q1
$27K Hold
86
0.01% 290
2019
Q4
$25K Sell
86
-11
-11% -$3.2K 0.01% 388
2019
Q3
$22K Sell
97
-28
-22% -$6.35K 0.01% 428
2019
Q2
$29K Sell
125
-28
-18% -$6.5K 0.01% 343
2019
Q1
$36K Buy
153
+3
+2% +$706 0.02% 365
2018
Q4
$45K Hold
150
0.02% 271
2018
Q3
$52K Hold
150
0.02% 286
2018
Q2
$43K Sell
150
-2
-1% -$573 0.02% 345
2018
Q1
$41K Sell
152
-19
-11% -$5.13K 0.02% 354
2017
Q4
$54K Sell
171
-1
-0.6% -$316 0.02% 284
2017
Q3
$53K Sell
172
-59
-26% -$18.2K 0.03% 244
2017
Q2
$62K Sell
231
-10
-4% -$2.68K 0.03% 208
2017
Q1
$65K Sell
241
-10
-4% -$2.7K 0.04% 199
2016
Q4
$71K Sell
251
-20
-7% -$5.66K 0.04% 188
2016
Q3
$84K Buy
271
+8
+3% +$2.48K 0.05% 158
2016
Q2
$63K Hold
263
0.04% 192
2016
Q1
$68K Sell
263
-10
-4% -$2.59K 0.04% 171
2015
Q4
$83K Buy
+273
New +$83K 0.05% 145